# Bionano Genomics, Inc.: Form 8-K, filed May 28, 2024

- Company: [Bionano Genomics, Inc.](/companies/bngo.md) (CIK 1411690)
- Form: 8-K
- Filed: 2024-05-28
- Accepted by EDGAR: May 28, 2024, 08:15 ET
- Period: 2024-05-23
- Accession: 0001140361-24-027553
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1411690/000114036124027553/ef20030067_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1411690/000114036124027553/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1411690/000114036124027553/ef20030067_8k.htm

Filed May 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-027553. Last ingested by Listed: Nov 11, 2026, 00:38 ET. No prices; not investment advice.
